XML 18 R6.htm IDEA: XBRL DOCUMENT v3.20.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 6 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Operating activities:    
Net loss $ (3,539) $ (2,558)
Adjustment to reconcile net loss to net cash:    
Depreciation and amortization 185 45
Common stock-based compensation and expenses, net 365 361
Changes in:    
Accounts receivables (134) (160)
Inventory (2,439) (2,860)
Deposits and advances (871) 3
Claims and advances 35 0
Accounts payable 239 555
Accrued and other liabilities (291) 170
Net cash used in operating activities (6,450) (4,444)
Investing activities:    
Purchase of property, plant and equipment (1,229) (2,049)
Proceed from /Investment in marketable securities 1,231 (5,039)
Investment in non-marketable securities (149) 0
Acquisition and filing cost of patents and rights (48) (23)
Net cash used in investing activities (195) (7,111)
Financing activities:    
Issuance of equity stock (net of expenses) 0 18
Proceeds from long- term loan 530 0
Net cash provided by financing activities 530 18
Effects of exchange rate changes on cash and cash equivalents 8 (10)
Net decrease in cash and cash equivalents (6,107) (11,547)
Cash and cash equivalents at the beginning of the period 7,258 25,610
Cash and cash equivalents at the end of the period 1,151 14,063
Supplementary information:    
Cash paid for interest 0 4
Non-cash items:    
Common stock issued/granted including ESOP, consultancy 365 361
Common stock issued/granted other than ESOP, consultancy $ 51 $ 0